(MedPage Today) — An investigational PET tracer that highlights beta-amyloid plaques within the brain and another that quantifies neuronal activity in specific regions both showed promising results in clinical studies aimed at identifying patients who are progressing toward Alzheimer’s disease.
http://www.medpagetoday.com/Geriatrics/AlzheimersDisease/27910
